Clinical Trials Browser

Phase 1/2 × OTHER × ebastine × Clear all

NCT06480110 2025-04-13

Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer

Phase 1/2 Recruiting

Metastatic Castration-resistant Prostate Cancer